Some people visit the hospital after a health checkup tells them their jaundice level is high or that the whites of their eyes have turned yellow, only to hear that a bile duct problem is suspected. Bile duct cancer often has no particular symptoms early on and is found late when the channel through which bile flows becomes blocked. That is why the diagnostic process does not end in one go but proceeds through several tests step by step — and for someone going through this for the first time, it can be frustrating to wonder "why do they keep doing so many tests."
Usually it starts with blood tests, abdominal ultrasound, and imaging such as CT or MRI. In particular, a magnetic resonance image called MRCP, which looks closely at the bile duct and pancreas, shows relatively clearly where and how much the bile duct has narrowed. Up to this point, it is the stage of taking pictures from outside the body, so the burden is not great. However, in many cases imaging alone makes it hard to be 100% certain whether the narrowed area is due to cancer or to another cause such as inflammation or a stone. That is when you move on to the next stage.
What often appears here is ERCP, which in full is endoscopic retrograde cholangiopancreatography. The name is long and sounds difficult, but in simple terms it is a test where an endoscope is passed through the mouth down to the duodenum, then a thin tube is inserted into the opening where the bile duct opens into the intestine, contrast dye is injected, and the inside of the bile duct is examined with X-rays. While directly confirming the blocked spot, if needed, a small tube called a stent is placed right there to let the bile drain and ease the jaundice. Being able to combine diagnosis and treatment in one go is a major advantage of ERCP. However, even when done under sedation, the pancreas can be irritated and pancreatitis can develop after the test, so the medical team watches closely for abdominal pain or fever afterward.
But seeing with your own eyes that the bile duct has narrowed does not let you immediately declare "it is cancer." In the end, you have to confirm under a microscope whether that tissue is actually cancer cells — and this is exactly what a biopsy is. While doing the ERCP, methods such as gently scraping cells from inside the narrowed bile duct with a brush (brush cytology) are used, or a small forceps removes a fragment of tissue. These days a thin endoscope is also inserted directly into the bile duct to look at the lesion and take a sample. However, because the bile duct is such a narrow and deep place, it is common not to catch enough cells in one go. So even if the biopsy comes back negative, if the imaging findings strongly suggest cancer, the test is repeated or another method is added to confirm. In other words, it is too early to relax just because one result was negative.
Because this whole process unfolds over a few days at the shortest and a few weeks at the longest, the patient and family burn with anxiety, wondering "when on earth will the results come out." That is entirely understandable. But because the treatment direction for bile duct cancer changes greatly depending on its location, this time spent carefully examining whether the narrowed spot is toward the liver or near the pancreas, and whether it has invaded the surrounding blood vessels, is in fact the foundation of the treatment plan. If the test schedule feels slow, it helps your peace of mind to ask the attending medical team, as you go, what stage you are at now and what they are trying to check next. If jaundice worsens between tests or is accompanied by fever or chills, you must report it right away without delay.
The content written here is only a general explanation meant to help you understand the bile duct cancer diagnostic process, and since the actual order and methods of testing differ from person to person, please be sure to discuss the details with your attending medical team.